Chemours Q2 FY26 net loss narrows 28% to $274 million; net sales slip 1% to $1.59 billion - CC News | RalliesChemours Q2 FY26 net loss narrows 28% to $274 million; net sales slip 1% to $1.59 billion
C
CC• Chemours reports narrower Q2 FY26 loss
- Chemours posted a GAAP net loss attributable to shareholders of $274 million, narrowing from a year-earlier loss of $380 million.
- GAAP diluted loss per share improved to $1.81, versus $2.53 a year earlier; net sales slipped 1% to $1.59 billion.
- Non-GAAP adjusted EBITDA edged down 5% to $247 million; non-GAAP adjusted EPS fell 31% to $0.42.
- Free cash flows more than doubled to $114 million, lifting free cash flow conversion to 46%; net leverage declined to 4.4x.
- Forecasts Q3 adjusted EBITDA of $175 million-$205 million; CEO Denise Dignam cited pricing momentum in TT and APM data center demand.
COLB
•
